Terumo: FDA 510(k) clearances across all its applicant names

FDA lists 563 510(k) clearances, 12 PMA and 0 De Novo decisions across the 25 applicant names Caduvo groups under Terumo, first 1976, latest 2026. Median 510(k) review time across these names: 73 days. Since 2017 the median was 174 days, against 138 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

510(k) clearances per year

YearClearancesMedian review days
20122053
20131757
201415158
20152684
2016984
201713175
201811174
20198115
2020790
20215202
20225264
20237197
20245210
202510140
20265192

The 25 FDA applicant names in this group

Applicant name510(k) clearancesPMADe NovoYears
Terumo Medical Corp.157301980–2023
MicroVention, Inc.86402001–2025
3M Health Care, Sarns76001976–1996
Terumo Cardiovascular Systems Corp.74002000–2024
Terumo Corp.34001991–2026
Terumo America, Inc.31001976–1981
Terumo Europe N.V.28001999–2025
Vascutek, Ltd.26101991–2025
Terumobct, Inc.8002013–2019
Ashitaka Factory of Terumo Corporation6002013–2021
Harvest Technologies, Corp.6002001–2012
Terumo Medical Products (Hangzhou) Co., Ltd.5002003–2025
Terumo (Philippines) Corporation5002012–2015
Kofu Factory of Terumo Corp.4002005–2014
Harvest Technologies, LLC3001999–2000
MicroVention, Inc., d/b/a Terumo Neuro3002026–2026
Caridianbct, Inc..2002010–2012
Terumo Clinical Supply Co., Ltd.2002021–2026
Bolton Medical, Inc.1302002–2002
Gambro Bct, Inc.1102007–2007
Ashitaka Factory of Terumo Coporation1002017–2017
MicroVention, Inc. A TERUMO Group Company1002019–2019
Terumo Bct1002015–2015
Terumo Cardiovascular Systems Thi Plant1002025–2025
Terumo Medical Coporation1002019–2019

Review time against the same product codes

Since 2017, 510(k)s cleared under these names took a median 174 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 138 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
DTZOxygenator, Cardiopulmonary Bypass3939
DWFCatheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass3333
HCGDevice, Neurovascular Embolization3232
FMINeedle, Hypodermic, Single Lumen3030
DYBIntroducer, Catheter2929
DQYCatheter, Percutaneous2424
DSYProsthesis, Vascular Graft, Of 6mm And Greater Diameter2222
DQXWire, Guide, Catheter2020
FMFSyringe, Piston2020
FPASet, Administration, Intravascular1818

Plus 118 more product codes.

Review panels

Most recent Terumo 510(k) clearances

510(k)DeviceApplicant nameProduct codeDecision dateReview days
K261376Progreat Lambda 2.1FrTerumo Clinical Supply Co., Ltd.KRA2026-11-05192
K254035Mayumi™ Thrombectomy SystemMicroVention, Inc., d/b/a Terumo NeuroQEZ2026-09-03261
K261808ISAAC Neurovascular Navigation CatheterMicroVention, Inc., d/b/a Terumo NeuroQJP2026-06-3029
K261549BOBBY Balloon Guide CatheterMicroVention, Inc., d/b/a Terumo NeuroQJP2026-06-0929
K252295RyureiTerumo Corp.LOX2026-03-27247
K252402Midline CatheterTerumo Medical Products (Hangzhou) Co., Ltd.PND2025-12-18140
K252398SURFLO Hybria Closed System Safety IV CatheterTerumo Medical Products (Hangzhou) Co., Ltd.FOZ2025-12-17139
K250700Pen Injector Needle 32.5Terumo Corp.FMI2025-11-21259
K250751DualView CatheterTerumo Corp.DQO2025-07-17127
K251447K-Pack Embrace Active Safety Needle (KNAS-2516RB, KNAS-2525RB)Terumo Europe N.V.FMI2025-07-0860

553 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P210030PMARoadsaver/CASPER Carotid Stent Device2024-11-20
P210017PMACross-Seal Suture-Mediated Vascular Closure Device System2023-09-26
P210006PMAThoraflex™ Hybrid2022-04-19
P200045PMARelayPro Thoracic Stent-Graft System2021-08-05
P190015PMATREO® Abdominal Stent-Graft System2020-05-04

Recalls

673 product recalls in 220 recall events under these names; 25 initiated in the last five years.

9 product recalls in 8 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 0 initiated in the last five years. Most often: Asahi Medical Co Ltd (2), Caridian BCT, Incorporated (2), St. Jude Medical / Daig Division (2).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

ClinicalTrials.gov lists 75 device studies (15 active or recruiting) with an industry lead sponsor under the 6 sponsor names below. Most recent:

Lead sponsor name on ClinicalTrials.govDevice studies
Terumo Europe N.V.22
Terumo BCT14
Bolton Medical13
Vascutek Ltd.13
Terumo Medical Corporation7
Harvest Technologies6

Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.

How this group is built

Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

3M's Sarns cardiovascular business (1999, now Terumo Cardiovascular), MicroVention (2006), CaridianBCT (formerly Gambro BCT, 2011, now Terumo Blood and Cell Technologies), Vascutek and Bolton Medical (2017). Includes filings made before each acquisition. Left out: COBE Laboratories (its businesses split among Terumo, Gambro and Sorin), joint ventures.

Sources

Frequently asked questions

How many FDA 510(k) clearances are listed across Terumo's applicant names?

FDA lists 563 510(k) clearances, 12 PMA and 0 De Novo decisions across the 25 applicant names Caduvo groups under Terumo, first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.

Which FDA applicant names does Terumo file under?

The names with the most 510(k) clearances in this group are Terumo Medical Corp. (157); MicroVention, Inc. (86); 3M Health Care, Sarns (76); Terumo Cardiovascular Systems Corp. (74); Terumo Corp. (34). The full list of 25 names is on this page.

How long does FDA take to clear Terumo 510(k)s?

The median time from FDA receipt to decision across 510(k)s cleared under these names is 73 days. Since 2017 the median was 174 days, against 138 days for all cleared 510(k)s in the same product codes.

Does the Terumo count include acquired companies?

Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.

How many device clinical trials does Terumo sponsor?

ClinicalTrials.gov lists 75 device studies (15 active or recruiting) with an industry lead sponsor under 6 sponsor names Caduvo groups under Terumo. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.

All parent companies · FDA device companies by applicant name · FDA product code lookup